secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2025-12-08T23:59:59+00:00
Accession:  0001746473-25-000179
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics CMO Éric Lefebvre to depart on Dec 15, 2025
---------------------------------------------------------------

- Chief Medical Officer Éric Lefebvre's employment terminates effective Dec 15, 2025.
- Lefebvre expected to assist as consultant post-Separation Date for transition support.
- No immediate replacement for CMO role announced by the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000174647325000179/0001746473-25-000179-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000174647325000179/plrx-20251202.htm
  HTML page:      https://secwatch.observer/filing/0001746473-25-000179

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer